PMID: 9177176Jun 10, 1997Paper

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

Proceedings of the National Academy of Sciences of the United States of America
N SinC M Crews

Abstract

The inhibition of new blood vessel formation (angiogenesis) is an effective means of limiting both the size and metastasis of solid tumors. The leading anti-angiogenic compound, TNP-470, has proven to be effective in in vitro and in animal model studies, and is currently being tested in phase III antitumor clinical trials. Despite many detailed pharmacological studies, little is known of the molecular mode of action of TNP-470. Using a derivative of the TNP-470 parent compound, the fungal metabolite, fumagillin, we have purified a mammalian protein that is selectively and covalently bound by this natural product. This fumagillin binding protein was found to be a metalloprotease, methionine aminopeptidase (MetAP-2), that is highly conserved between human and Saccharomyces cerevisiae. In the absence of MetAP-1, a distantly related methionine aminopeptidase, MetAP-2 function is essential for vegetative growth in yeast. We demonstrate that fumagillin selectively inhibits the S. cerevisiae MetAP-2 protein in vivo. The binding is highly specific as judged by the failure of fumagillin to inhibit MetAP-1 in vivo. Hence, these results identify MetAP-2 as an important target of study in the analysis of the potent biological activities of...Continue Reading

References

Jan 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M K RayN K Gupta
Mar 1, 1992·Chemical & Pharmaceutical Bulletin·S Marui, S Kishimoto
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B DattaN K Gupta
Jan 1, 1974·Advances in Cancer Research·J Folkman
Oct 1, 1993·Journal of Pediatric Surgery·H BremJ Folkman
Sep 1, 1994·Pharmacology & Therapeutics·W Auerbach, R Auerbach
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·S M ArfinR A Bradshaw
Feb 1, 1995·Journal of Pediatric Surgery·M S O'ReillyJ Folkman
Apr 1, 1994·Neurological Research·J T Wilson, P L Penar
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·X Li, Y H Chang
Aug 5, 1996·Biochemical and Biophysical Research Communications·A E BudsonJ Bischoff
Aug 1, 1996·Trends in Biochemical Sciences·P J Keeling, W F Doolittle

❮ Previous
Next ❯

Citations

Nov 9, 2004·Chembiochem : a European Journal of Chemical Biology·John S Schneekloth, Craig M Crews
Jan 10, 2003·Chirality·David A VosburgErik J Sorensen
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Kazuhito ArakawaTakuma Sasaki
Dec 29, 1998·Protein Science : a Publication of the Protein Society·K W Walker, R A Bradshaw
Jan 29, 2002·Archives of Biochemistry and Biophysics·Shaoping ChenYie-Hwa Chang
May 11, 2000·Analytical Biochemistry·Y ZhouD Pei
Jan 26, 2002·Journal of Biomedical Science·Pent ZhangPeter K Chiang
Apr 7, 2007·The Journal of Membrane Biology·Shunsuke NoguchiMasaru Kawamura
Jul 10, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Gregory M LanzaSamuel A Wickline
Dec 4, 2004·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Ventris M D'souzaRichard C Holz
Feb 10, 2009·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Sanghamitra MitraRichard C Holz
Apr 20, 2006·International Journal of Clinical Oncology·Shigeru KandaHiroshi Kanetake
Nov 2, 2004·Angiogenesis·Thomas GarrabrantDana L Johnson
Dec 25, 2010·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Dongxiao YaoXianli Zhu
Mar 17, 2004·Biochimica Et Biophysica Acta·Florence Bordon-PallierJean-Luc Haesslein
May 25, 2013·Biomaterials·Goutam MondalArabinda Chaudhuri
Nov 8, 2003·Bioorganic & Medicinal Chemistry·Maria FardisBrian Hicke
Dec 20, 2003·Bioorganic & Medicinal Chemistry Letters·Hyung-Jung PyunChoung U Kim
Dec 20, 2003·Bioorganic & Medicinal Chemistry Letters·Xubo HuDehua Pei
Jan 27, 2004·Bioorganic & Medicinal Chemistry Letters·Dong ZhangKyungbo Kim
Mar 12, 2004·Bioorganic & Medicinal Chemistry Letters·George S SheppardRichard Lesniewski
Feb 29, 2000·Journal of Pediatric Surgery·S C ChiangS L Moulton
Dec 30, 1999·Immunopharmacology·S M OliveiraK B Alves
Jul 17, 1998·Trends in Pharmacological Sciences·H G Augustin
Mar 10, 2000·Biochimica Et Biophysica Acta·W T Lowther, B W Matthews
Nov 7, 2002·Bioorganic & Medicinal Chemistry Letters·J Brad ShotwellCraig M Crews
Jan 15, 2000·Bioorganic & Medicinal Chemistry Letters·C K HanK T No
May 14, 2003·Trends in Cell Biology·Thomas U Mayer
Dec 12, 2001·Bioorganic & Medicinal Chemistry·Kwang-Hee SonByoung-Mog Kwon
Oct 24, 1998·Bioorganic & Medicinal Chemistry·N SinC M Crews
Jun 22, 2001·Critical Reviews in Oncology/hematology·P A Burke, S J DeNardo
Jul 10, 2003·Critical Reviews in Oncology/hematology·Walter Stadler, George Wilding

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.